{
    "Trade/Device Name(s)": [
        "HCG Home Use Pregnancy Test Strip (Colloidal Gold)",
        "HCG Home Use Pregnancy Test Cassette (Colloidal Gold)",
        "HCG Home Use Pregnancy Test Midstream (Colloidal Gold)"
    ],
    "Submitter Information": "ANHUI DEEPBLUE MEDICAL TECHNOLOGY CO.,LTD.",
    "510(k) Number": "K240242",
    "Predicate Device Reference 510(k) Number(s)": [
        "K200133"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "September 2, 2024",
    "Summary Letter Received Date": "September 5, 2024",
    "Submission Date": "October 11, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Collection container",
        "Test cassette well",
        "Midstream test device (direct collection)"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Colloidal gold technology"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Strip",
        "Cassette",
        "Midstream",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for ANHUI DEEPBLUE HCG Home Use Pregnancy Tests (strip, cassette, midstream formats) for qualitative detection of hCG in urine via immunochromatographic assay",
    "Indications for Use Summary": "Qualitative, over-the-counter home detection of human chorionic gonadotropin (hCG) in urine to aid in the early detection of pregnancy",
    "fda_folder": "Clinical Chemistry"
}